Alphatec Holdings Hits Day Low at $8.52 Amid Price Pressure

Alphatec Holdings, Inc., a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced significant volatility today, with the stock hitting an intraday low of USD 8.52. The company has seen a notable decline of 7.93% in its stock price as of July 17, 2026, contrasting sharply with the S&P 500's decline of just 1.01% on the same day. Over the past week, Alphatec's performance has been even more pronounced, with a drop of 10.91%, while the S&P 500 fell by 1.55%. Year-to-date, the stock has plummeted by 59.43%, significantly underperforming the S&P 500, which has gained 8.94% during the same period. Alphatec's long-term fundamentals appear weak, with an operating profit decline of 5.79% annually over the last five years. The company also faces challenges in servicing its debt, reflected in a high Debt to EBITDA ratio of 23.26 times. With a market capitalization of USD 1,674 million, Alphatec continues to navigate a challenging financial landscape, marked by consistent underperformance against industry benchmarks.